08:00 , Mar 22, 2004 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Aponetics AG Witterswil, Switzerland Technology: GFP-based compound screening Disease focus: Cancer Clinical status: Preclinical Founded: 2000 by Alessandro Strebel, Thomas Harr, Jost Harr and Felix Bachmann Corporate partners: Polyphor Ltd. University collaborators: Universities of Basel...
08:00 , Mar 22, 2004 |  BioCentury  |  Emerging Company Profile

Aponetics: Put out the green light

Oncology is a crowded space, and a company wishing to stand out in the field must have good targets and a technology that can provide a steady stream of novel compounds. Aponetics AG says it...